Conditions: Esophageal Cancer Stage IIB; Esophageal Cancer Stage III
Interventions: Combination Product: Paclitaxel, Cisplatin Plus 5-FU (TCF); Radiation: radiochemotherapy
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Shanghai Chest Hospital; Henan Cancer Hospital; The First Affiliated Hospital with Nanjing Medical University; First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Anhui Medical University
Not yet recruiting
http://ift.tt/2kDbM7z
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου